v3.26.1
Income Taxes (Details Narrative)
12 Months Ended
Dec. 31, 2025
USD ($)
Jul. 31, 2025
USD ($)
Jul. 31, 2025
MYR (RM)
Dec. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
Jul. 31, 2025
MYR (RM)
Jul. 31, 2025
SGD ($)
Jul. 31, 2024
MYR (RM)
Jul. 31, 2024
SGD ($)
Jul. 31, 2023
USD ($)
Titan Pharmaceuticals Inc [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Changes in valuation allowance $ 5,300,000     $ 4,500,000            
Unrecognized tax benefits $ 0                  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 21.00%     21.00%            
Additional Paid in Capital $ 400,576,000     $ 398,974,000            
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount (522,000)     (980,000)            
Deferred Tax Assets, Valuation Allowance 55,142,000     $ 60,480,000            
TALENTEC SDN. BHD. [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Additional Paid in Capital   $ 782,865     $ 782,865 RM 2,500,000        
Gross Profit   884,928 RM 50,000,000   686,835          
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount   35,685     26,049          
Deferred Tax Assets, Valuation Allowance   $ 146,561     $ 189,010         $ 242,146
TALENTEC SDN. BHD. [Member] | In Excess Of RM600,000 [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent   24.00% 24.00%   24.00%          
TALENTEC SDN. BHD. [Member] | The First RM600,000 [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent   17.00% 17.00%   17.00%          
Gross Profit | RM     RM 600,000              
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount   $ 150,000                
TALENTEC SDN. BHD. [Member] | Inland Revenue, Singapore (IRAS) [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent   17.00% 17.00%              
Unabsorbed tax losses   $ 711,845     $ 641,054   $ 923,761   $ 857,217  
TALENTEC SDN. BHD. [Member] | The Inland Revenue Board Of Malaysia [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Unabsorbed tax losses   $ 150,278     $ 470,769 RM 640,561   RM 2,160,122    
Domestic Tax Jurisdiction [Member] | Titan Pharmaceuticals Inc [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Operating loss carryforwards 109,600,000                  
Operating loss carry forwards not subject to expiration $ 66,800,000                  
Operating loss carryforwards, limitations on use percentage 0.80                  
Domestic Tax Jurisdiction [Member] | Titan Pharmaceuticals Inc [Member] | Research Tax Credit Carryforward [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Operating loss carryforwards $ 4,400,000                  
California Franchise Tax Board [Member] | Titan Pharmaceuticals Inc [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Operating loss carryforwards 121,500,000                  
State and Local Jurisdiction [Member] | Titan Pharmaceuticals Inc [Member] | Research Tax Credit Carryforward [Member]                    
Income Tax Paid, by Individual Jurisdiction [Line Items]                    
Tax credit carryforward, amount $ 9,100,000